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microRNAs (miRNAs) are a class of small non-coding RNAs acting as post-transcriptional regulators of
gene expression and play fundamental roles in regulating immune response and autoimmunity.
We show that memory T-lymphocytes express higher levels of miR-21 compared to naïve T-lym-
phocytes and that miR-21 expression is induced upon TCR engagement of naïve T-cells. We identify bona
ﬁdemiR-21 targets by direct immuno-puriﬁcation and proﬁling of AGO2-associated mRNAs in Jurkat cells
over-expressing miR-21. Our analysis shows that, in T-lymphocytes, miR-21 targets genes are involved in
signal transduction. Coherently, TCR signalling is dampened upon miR-21 over-expression in Jurkat cells,
resulting in lower ERK phosphorylation, AP-1 activation and CD69 expression. Primary human lym-
phocytes in which we impaired miR-21 activity, display IFN-g production enhancement and stronger
activation in response to TCR engagement as assessed by CD69, OX40, CD25 and CD127 analysis. By
intracellular staining of the endogenous protein in primary T-lymphocytes we validate three key regu-
lators of lymphocyte activation as novel miR-21 targets.
Our results highlight an unexpected function of miR-21 as a negative modulator of signal transduction
downstream of TCR in T-lymphocytes.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Recent studies pinpoint miRNAs as major players in the mo-
lecular circuitries that control development and differentiation of
haematopoietic lineages. miRNAs are a class of small non-coding
RNAs which modulate gene expression at post-transcriptional
level [1]. These tiny RNA molecules are incorporated into the RISC
(RNA Induced Silencing Complex) by tight association with Argo-
naute (AGO1-4) proteins. RISC exerts its regulatory function
through impairment of target mRNA translation and/or mRNA de-
stabilization [1]. Computational predictions suggest that each sin-
gle miRNA could affect the expression of hundreds of proteins [2].
Several reports highlighted key roles for miRNAs in the develop-
ment and function of lymphocytes [3].ogie Cellulari ed Ematologia,
V Clinica Medica, V.le Regina
.
B.V. This is an open access article uTCR stimulation triggers proliferation and activation of naïve T-
lymphocytes by a complex signal transduction cascade, ﬁnally
resulting in activation of NFAT, AP-1, NFkB and other transcription
factors. The subsequent wave of mRNA transcription and protein
translation leads to the differentiation of resting naïve T-cells into
effector and memory T-lymphocytes. Sub-threshold signals may
result in anergy, apoptosis or low expansion of memory cells which
are unable to mount a proper immune response.
We show that miR-21 is highly expressed in human central
memory T-lymphocytes compared to naïve T-cells. This is consis-
tent with previous reports describing miR-21 expression in mem-
ory CD8þ cells in mice [4], in lymphocytes of patients affected by
Systemic Lupus Erythematosus [5] as well as in lymphocytes of PD-
1 knock-out mice [6]. In mice miR-21 is a limiting factor of immune
response [7]. A tumorigenic role has also been highlighted for this
miRNA [8]. Nevertheless, an extensive characterization of miR-21
targets is lacking and mechanistic details of its mode of action in
T-lymphocytes are still unknown. Identiﬁcation of miRNA targets is
mandatory for molecular characterization of their function. Ca-
nonical targets are recognized by pairing between their 30 UTR andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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termed seed [9]. Several bioinformatic approaches have been
developed to predict miRNA targets [10]. Recently, biochemical
puriﬁcation of miRNA targets via RISC/miRNA pull down has been
exploited [11,12]. This approach unveils that a relevant fraction of
miRNA targets lack canonical seed complementarity and aremissed
by most prediction algorithms.
We demonstrated that miR-21 expression in primary human T-
lymphocytes affects TCR signalling. By an unbiased high-
throughput biochemical approach, we identiﬁed speciﬁc in-
teractions between miR-21 and a large group of mRNAs encoding
for key players of TCR signal transduction and lymphocyte activa-
tion. We validate three of the identiﬁed targets by intracellular
staining of endogenous protein in primary T-cells. Our results show
that miR-21 expression affects ERK phosphorylation, AP-1 activity
and T-cell activation and interleukins (IFN-g) production upon TCR
engagement, highlighting a role of miR-21 as a negative regulator of
T-lymphocyte activation.Fig. 1. miR-21 is expressed at higher levels in central memory T-lymphocytes and is
induced upon TCR engagement of T-lymphocytes in vitro. A) Heatmap of miRNA
expression proﬁle of T-lymphocytes (CD4þ naïve, CD4þ memory, CD8þ naïve and CD8þ
central memory cells) from peripheral blood of healthy donors. B) miR-21 expression
was quantiﬁed by qRT-PCR in CD4þ naïve and central memory cells of healthy donors.
C) miR-21 expression in T-lymphocytes following stimulation by anti CD3/CD28 anti-
bodies. D) miR-21 expression is speciﬁcally induced in the T-ALL cell line Jurkat upon
treatment with anti CD3/CD28 antibodies.2. Materials and methods
2.1. Microarray data
microRNA microarray assay was performed using a service
provider (LC Sciences). GEO repository accession: GSE16453.
Primary CD4þ lymphocytes were assayed for gene expression by
using the Affymetrix Human Gene 1.0 ST array (3 replicates). GEO
repository accession: GSE37213.
Details are provided in supplementary experimental
procedures.2.2. qRT-PCR of mature miRNAs
qRT-PCR of mature miR-21 was performed as described previ-
ously [13].2.3. Lentiviral transduction
Viral particles were obtained by co-transfection of 293T-cells
with lentiviral plasmid and the PLP-1, PLP-2 and PLP-VSVG plas-
mids (Invitrogen) and concentrated by ultra-centrifugation. Jurkat
cells were transduced at anMOI of 15 and selectedwith puromycin.Fig. 2. Jurkat cells overexpressing miR-21 are less responsive to TCR stimulation. A)
Assessment of CD69 positive cells 24 h after CD3/CD28 stimulation; Jurkat_pRRL-Ctrl
and Jurkat_pRRL-21 cells are compared to parental Jurkat cells. Average of three in-
dependent experiments is reported. Error bars represent SEM. B) AP-1 reporter activity
is depicted for Jurkat_pRRL-Ctrl and Jurkat_pRRL-21, non stimulated and CD3/CD28
stimulated cells were analysed. Average of three independent replicas is reported.
Error bars represent SEM. C) Western blot analysis of ERK phosphorylation. Cells were
stimulated and harvested at the indicated time-points. One representative experiment
of four independent replicas is shown. D) Densitometric analysis of four independent
replicas of phosphoERK western blot.
C. Carissimi et al. / Biochimie 107 (2014) 319e326 321Primary CD4þ cells were activated using Invitrogen anti CD3/
CD28 Dynabeads and transduced at an MOI of 15 with polybrene.2.4. Jurkat cell activation
Culture plates were incubated O/N at 4 C with a polyclonal
rabbit anti-mouse immunoglobulins (Dako). 150 ml of aCD3 (okt-3)
and aCD28 were added. The plates were incubated for 4 h at 37 C.
Cells were plated on the Ab-coated wells and incubated for the
indicated times.2.5. AP-1 reporter assay
Cells were cotransfected with 3 mg of AP-1 reporter construct
and 1 mg of the pRLTK plasmid using Lipofectamine 2000 (Invi-
trogen), according to manufacturer instructions. Following trans-
fection cells were split, in one well the cells were activated with
CD3/CD28 antibodies, while the other well was used as a non-
activated control. Luciferase activity was assessed using Dual
Luciferase assay (Promega).Fig. 3. RISC-IP to identify miR-21 targets in Jurkat_pRRL-Ctrl and Jurkat pRRL-miR-21. A) We
miRNA-16 abundance was measured by qRT-PCR immunoprecipitates in total lysate, AGO
speciﬁcally bound to RISC (AGO2 signal > IgG signal) in pRRL-21 cells compared to the freque
within 30 UTRs of genes not speciﬁcally bound to RISC (AGO2 signal < IgG signal) in pRRL-21
value (binomial probability).2.6. RISC immunopuriﬁcation
Jurkat cells were lysed in lysis buffer (20 mM TriseHCl, pH 7.5;
150 mM KCl; 0.5% Nonidet P-40; 2 mM EDTA; 0.5 mM DTT; 1 mM
NaF; 40 u/ml RNasin). Lysates were clariﬁed and pre-cleared by
protein-G sepharose beads. An aliquot of total extract was taken out
(Input). Monoclonal anti-AGO2 (11A9, Ascenion) and an equal
amount of puriﬁed rat IgG (SIGMA) were incubated with the pre-
cleared lysate. Samples were washed with lysis buffer and wash
buffer (50 mM TriseHCl, pH 7.5; 300 mM NaCl; 5 mM Mg2Cl; and
0.05% Nonidet P-40), treated with DNaseI-RNase-free (Promega)
and subject to proteinase K digestion. After ﬁnal wash an aliquot
was taken out for western.
3. Results
3.1. Differential miRNA expression proﬁle between naïve and
memory T-lymphocytes
We looked at the miRNA expression proﬁle of naïve and central
memory T-lymphocytes in the CD4þ and CD8þ lineages, sortedstern blot of the immunoprecipitated protein, AGO2 and IgG samples. B) miRNA-21 and
2 and IgG samples. C) Black area: frequency of miR-21 seed within 30 UTRs of genes
ncy of miR-21 seed in the expressed mRNAs; light grey area: frequency of miR-21 seed
cells compared to the frequency of miR-21 seed in the expressed mRNAs; red line: P-
Fig. 4. miR-21 inhibition results in stronger activation of T-lymphocytes. Primary CD4þ lymphocytes were transduced with miR-21_sponge or CTRL_sponge constructs (carrying
GFP as reporter), expanded for 6 days with CD3/CD28 Dynabeads and restimulated (or not) overnight with 5 mg/ml of soluble anti-CD3/CD28 antibodies. A) Representative dot plot
showing CD45RA versus CD45RO expression. Data show not restimulated, gated GFPþ T-cells, from one out of 4 independent experiments. B) Histogram overlay of CD25, CD127 and,
OX40 and CD69 expression in gated GFPþ cells. Numbers in each plot represent the mean ﬂuorescence intensity (MFI) of markers. Data are representatives of one of 3 independent
experiments. C) Intracellular staining of IL-2 and IFN-g in gated GFPþ primary CD4þ lymphocytes transduced with miR-21_sponge or CTRL_sponge constructs, restimulated (or not)
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CD45RACD45ROþCCR7þ cells, respectively. Overall, CD4þ and
CD8þ naïve cells showed similar proﬁle, as well as CD4þ and CD8þ
central memory cells. A few miRNAs (miR-15a, miR-21, miR-24,
miR-27a, miR-27b, miR-146a and miR-101) were differentially
expressed in central memory compared to naïve cells in both CD4þ
and CD8þ lineages (Fig.1A).
We focus on miR-21, which was previously shown to act as an
anti-apoptotic factor and to be over-expressed in several tumours
[8]. qRT-PCR analysis conﬁrmed that central memory CD4þ T-
lymphocytes express miR-21 at a ﬁve-fold higher level compared to
naïve cells (Fig.1B).
3.2. miR-21 expression is induced via TCR stimulation and is related
to a memory phenotype
To verify whether miR-21 expression is a consequence of TCR
engagement, naive CD4þ T-lymphocytes from healthy donors were
treated with anti-CD3/CD28 agonistic antibodies [14]. We observed
an up-regulation of miR-21 (Fig.1C) consistent with what observed
during naïve-to-memory transition in CD4þ T-lymphocytes. miR-21
expression is detectable within 24 h of stimulation reaching a
plateau after 3 days and remaining high afterwards for at least 11
days. Similar results were obtained using PMA/ionomycin, which
activate signal transduction downstream of TCR (Supplementary
Fig. 1). This process was recapitulated also in Jurkat cells (Fig.1D),
a model for the study of TCR signal transduction in a cell line. These
data demonstrate that miR-21 expression in T-lymphocytes is
triggered by TCR stimulation and costimulation.
3.3. Expression of miR-21 prior to TCR stimulation results in
dampened stimulation
We over-expressed miR-21 in Jurkat cells by transductionwith a
lentiviral transgenic construct encoding for miR-21 under a PGK
promoter (pRRL-21) [15]. A cognate vector encoding for a control
hairpin was used to generate control cell line (pRRL-Ctrl).
Jurkat_pRRL-21 cell line over-expressed miR-21 roughly 20-fold
higher compared to Jurkat_pRRL-Ctrl (Supplementary Fig. 2A),
this is comparable to the expression attained following TCR/CD28
stimulation in the parental cell line. Jurkat_pRRL-Ctrl express miR-
21 at levels comparable to those observed in parental cell line prior
to stimulation (Supplementary Fig. 2B).
Since it has been reported that transfection of miRNAs may
displace endogenous miRNAs from RISC [13], we checked by deep
sequencing the proﬁle of miRNAs loaded on AGO2 (Supplementary
Table 2). In Jurkat pRRL-21, AGO2-bound miR-21 was up-regulated
without signiﬁcantly affecting association of other miRNAs with
AGO2.
We found that Jurkat_pRRL-21 cells were less responsive than
Jurkat_pRRL-Ctrl cells to anti-CD3/CD28 stimulation, we observed a
highly reproducible (P¼ 0.0008) decrease in expression of the early
activation marker CD69 in pRRL-21 compared to pRRL-Ctrl cells
(Fig. 2A).
CD69 expression is driven by several transcription factors
downstream of TCR engagement, such as AP-1 and NF-kB [16]. We
assessed activity of these transcription factors by using luciferase
reporter constructs. No signiﬁcant change in NF-kB activity was
detect (data not shown). On the contrary, Jurkat_pRRL-21 cells,overnight with anti-CD3/CD28 and activated 4 h with Cell Stimulation Cocktail plus protei
validation of bona ﬁde miR-21 targets. miR-21_sponge and CTRL_sponge cells were surface s
anti-VDAC primary Abs. As negative control, unstained cells (for CXCR4) or cells stained with
each plot represent the ratio between MFI in miR_21 sponge and MFI in CTRL_sponge. Datcompared to Jurkat_pRRL-Ctrl cells, displayed signiﬁcantly lower
induction of AP-1 reporter activity after TCR stimulation (P¼ 0.026,
Fig 2B). AP-1 is a transcription factor downstream of the MAP ki-
nase cascade activated by RAS [17]. We therefore measured ERK
phosphorylation, which is also triggered by RAS activation and is an
established marker of RAS activity in response to TCR engagement.
Fig. 2CeD shows a signiﬁcant decrease of the ERK phosphorylated
forms in pRRL-21 cells compared to pRRL-Ctrl at 5 min after stim-
ulation. These data conﬁrm that miR-21 expression in T-lympho-
cytes affects signal transduction downstream of TCR.
3.4. High-throughput biochemical identiﬁcation of miR-21 targets
We set out to identify miR-21 targets using a high-throughput
biochemical approach. Using a monoclonal antibody against
AGO2, RNA associated to RISC complexes were immunopuriﬁed
from pRRL-21 and pRRL-Ctrl Jurkat cells. As a control, we per-
formed a parallel immunoprecipitation using isotype-matched rat
IgG (Fig 3A). miRNA abundance was measured by qRT-PCR. High
levels of miR-16 (Fig. 3B), let-7f, miR-142-5p (data not shown) were
found in both AGO2 immunoprecipitates but not in IgG controls. In
agreement with miR-21 up-regulation, high levels of miR-21 were
speciﬁcally found in AGO2 immunoprecipitates from pRRL-21 cell
lysates, and not pRRL-Ctrl AGO2 and IgG controls (Fig 3B). To
identify mRNAs speciﬁcally recruited onto RISC upon miR-21 over-
expression, we proﬁled AGO2-bound mRNAs from pRRL-21 and
pRRL-Ctrl cell lysates (herein referred to as 21_AGO2 and
Ctrl_AGO2 samples) and control IgG captured mRNAs (herein
referred to as 21_IgG and Ctrl_IgG samples) by microarray analysis.
We compared AGO2-bound mRNAs in pRRL-21 and pRRL-Ctrl
cell lines. We used 21_IgG and Ctrl_IgG to discriminate mRNAs
aspeciﬁcally bound to AGO2 antibody and/or sephadex protein-G
beads. For each mRNA the ratio between (21_AGO2/21_IgG)/
(Ctrl_AGO2/Ctrl_IgG) was used to rank candidate miR-21 targets
(Supplementary Fig. 3 and Supplementary experimental pro-
cedures). We computed frequencies of different miRNA seeds in the
30 UTRs of those mRNAs speciﬁcally associated to RISC in pRRL21
cells. We found a signiﬁcantly higher frequency of miR-21 seed
matches within 30 UTRs of mRNAs bound to RISC only in pRRL-21
cells when compared to the general frequency among the
expressed mRNAs (P-value < 1 E10, Fig 3C). No signiﬁcant in-
crease in seed frequency was observed in the same 30 UTRs for
miRNAs which are highly expressed in both pRRL-21 and pRRL-Ctrl
cells or miRNAs which are not expressed in these cell lines. These
observations conﬁrm that our approach effectively identiﬁes bona
ﬁde miR-21 targets.
3.5. Functional annotation enrichment analysis (GO terms)
highlights a role of miR-21 targets in key process for lymphocyte
activation and differentiation
We performed a GO term analysis [18] to identify the pathways
in which mRNAs bound by miR-21 are involved. We ranked mRNAs
according to their binding to RISC speciﬁcally in pRRL-21 cells and
submitted the list to a GO term enrichment analysis tool [19]. The
enriched Biological Process GO term categories (Supplementary
Fig. 4) were related to GTP metabolism, regulation of lymphocyte
development and cell differentiation. Strikingly, Molecular Func-
tion Annotation (Supplementary Fig. 4A) yielded only categoriesn transport inhibitors. Data are representative of 4 independent experiments. D) FACS
tained with anti-CXCR4 Ab, or intracellularly stained with anti-PLEKHA1, anti-GNAQ or
secondary Ab alone are shown. Numbers in each legend show MFI, while numbers in
a are representative of more than three independent replicates.
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Component (Supplementary Fig. 4B) pointed to cell membrane and
vesicles. These data indicate a role of miR-21 in the inhibition of
small GTPases-mediated and membrane-associated signal trans-
duction, a key process for lymphocyte activation and
differentiation.
3.6. Analysis of miR-21 role in primary T-lymphocyte activation
We exploited a more physiological system, namely primary
naïve CD4þ T-lymphocytes sorted from peripheral blood of healthy
donors and activated in vitro. We took advantage of lentiviral
transduction. Efﬁcient lentiviral transduction of primary T-lym-
phocytes requires T-cell activation that is followed by strong miR-
21 induction (Fig. 1). We set out to inhibit miR-21 function by us-
ing a sponge construct [20], rather than to further increase its
expression in activated T-lymphocytes. Eight sequences comple-
mentary to miR-21 except for a bulge (nt 12e13), were cloned in a
lentiviral vector downstream of a GFP reporter, thus obtaining the
miR-21_sponge construct [15]. A cognate vector containing a con-
trol sequence was used as a control (CTRL_sponge). Efﬁcient titra-
tion of miR-21 by miR-21_sponge construct was assayed in Jurkat
cells (Supplementary Fig. 5).
Primary naïve CD4þ CD45RAþ T-cells were activated by CD3/
CD28 beads and transduced with the above described lentivirus,
ﬁve days later cells were re-activated with a milder stimulus (sol-
uble anti-CD3/CD28 antibodies at low concentrations). The extent
of cell activationwas monitored by ﬂow cytometry. miR-21_sponge
expressing cells displayed higher levels of CD45RO acquisition and
lower levels of CD45RA downregulation, suggesting that miR-21
inhibition results in a faster differentiation toward a memory
phenotype (Fig 4A). We also highlighted higher levels of CD69,
CD25, and OX40 expression and lower levels of CD127 expression in
miR-21_sponge cells compared to CTRL_sponge cells. In particular,
CD25 and OX40 levels were higher both before and after re-
stimulation, even though OX40 was induced upon re-stimulation
at much higher levels in miR-21_sponge cells (Fig. 4B). On the
other hand, CD69 was speciﬁcally increased and CD127 speciﬁcally
decreased inmiR-21_sponge cells only upon re-stimulation. Overall
the expression pattern of these markers indicates that miR-21 in-
hibition favours T-cell activation and re-activation.
We also tested cytokine production in miR-21_sponge cells.
While IL-2 secretion seemed to be unaffected, we could detect a
signiﬁcant increase in IFN-g production in miR-21_sponge cells
(Fig. 4C).
The above-described alterations were not a mere consequence
of increased proliferation/survival. Indeed, the analysis of prolifer-
ation rate by E-ﬂuor 670 labelling did not highlight any signiﬁcant
alteration. Despite the reported role of miR-21 as an anti-apoptotic
factor, no signiﬁcant differences were observed whenmeasuring by
TUNEL assay apoptosis induction in response to CD3 stimulus in
miR-21_sponge and CTRL_sponge cells (data not shown).
3.7. Microarray analysis of miR-21_sponge and CTRL_sponge
transduced primary T-lymphocytes
We performed mRNA expression proﬁle of miR-21_sponge and
CTRL_sponge transduced cells. Seed analysis does not reveal a sig-
niﬁcant enrichment for miR-21 seed in the mRNAs upregulated in
miR-21_sponge samples (Supplementary Fig. 6), suggesting that
those are secondary targets of miR-21. Coherently, mRNA expres-
sion proﬁles of Jurkat_pRRL-21 and Jurkat_pRRL-Ctrl did not
highlight any bias toward primary miR-21 targets downregulation.
However, GO term annotation is consistent with the observed
phenotype (Supplementary Fig. 7), highlighting that mRNAs whoseexpression is affected by miR-21 sponge are involved in immune
response.
3.8. Validation of biochemically identiﬁed miR-21 targets
We conﬁrm our biochemical target identiﬁcation approach by
intracellular ﬂow cytometric analysis of endogenous protein in
miR-21_sponge compared to CTRL_sponge primary CD4þ T-cells.
We chose a set of bona ﬁde targets for validation which have pre-
viously been involved in regulation of T-lymphocyte activation
(PLEKHA1 [21], GNAQ [22], RAC1 [23], OGT [24] and CXCR4 [25])
and another set of targets not implicated in T-lymphocyte activa-
tion (RAB14 and VDAC).Wewere able to speciﬁcally stain PLEKHA1,
GNAQ, CXCR4 and VDAC, while we could not obtain sufﬁcient
speciﬁcity (compared to negative controls) for RAC1, OGT and
RAB14. This analysis shows that three of four genes selected were
up-regulated in T-lymphocytes upon miR-21 inhibition (Fig. 4D).
4. Discussion
miR-21 expression in T-lymphocyteswas reported in association
with autoimmune diseases such as SLE [5] and psoriasis [26], as
well as in Sezary syndrome [27]. Interestingly, silencing of miR-21
ameliorates splenomegaly in SLE [28]. More recently, the role of
miR-21 has been explored in primary human T-lymphocytes
showing that miR-21 plays opposing roles in naïve and memory T-
cells [29]. Furthermore, transfection of primary murine lympho-
cytes with miR-21 suggested that this miRNA might boost T-cell
activation [30]. However, a loss of function approach in mice has
shown that miR-21 limits immune response-mediated activation of
the IL-12/IFN-gamma pathway and Th1 polarization [7]. The use of
different model systems (ex vivo cultured human and murine pri-
mary T-lymphocytes, lymphoblastic cell lines) and, more impor-
tantly, different methods (in vivo approaches, transfection,
lentiviral transduction) does not allow a direct comparison of these
partially conﬂicting results.
Although a few putative miR-21 targets in T-lymphocytes have
been tested, an exhaustive characterization of miR-21 function at
molecular level in human T-lymphocytes is still lacking.
We demonstrate that repression of signal transduction by miR-
21 occurs upstream of CD69 expression, by showing that both AP-1
activity and ERK phosphorylation are affected by miR-21. Multiple
markers of T-lymphocyte activation (CD69, CD25, OX40) are up-
regulated in primary T-lymphocytes by speciﬁc inhibition of miR-
21 activity. We also report higher IFN-g production by miR-21-
depleted primary T-lymphocytes. This phenotype is corroborated
by mRNA proﬁle in primary lymphocytes, highlighting de-
regulation of mRNAs involved in immune response upon miR-21
depletion.
To characterize the role of miR-21 in human T-lymphocytes, we
exploited a high-throughput biochemical approach, that allows
direct identiﬁcation of miRNA targets in the cell type of interest. Via
lentiviral transduction, we obtained a miR-21 upregulation closely
resembling the physiological upregulation observed upon T-cell
activation and identiﬁed hundreds of bona ﬁde miR-21 target
mRNAs speciﬁcally recruited onto AGO2. mRNA-targets display a
signiﬁcant enrichment for 7-mers sequences complementary to
miR-21 seed in their 30 UTRs and a strong enrichment for GO cat-
egories associated with signal transduction. miR-21 inhibition in
primary T-lymphocytes results in an increased expression of 3 out
of 4 measured bona ﬁde miR-21 targets (PLEKHA1, CXCR4, GNAQ,
VDAC), yielding a validation rate of our bona ﬁde miR-21 targets of
75%.
These novel targets point to miR-21 as a negative regulator of
signal transduction in T-lymphocytes. We show that miR-21 co-
C. Carissimi et al. / Biochimie 107 (2014) 319e326 325ordinately affects expression of a large number of targets, while
having a mild effect on target mRNA stability. Nevertheless, ﬁne-
tuning of a large number of targets converging on few pathways
results in a robust and reproducible phenotype.
Our results are in line with the observations by Lu and col-
leagues [7]. On the contrary, Wang and co-workers [30] obtained
different results by miR-21 transfection into murine T-lymphoctes
and Jurkat cells. However, it should be noted that in our experi-
mental setting a 20-fold upregulation of miR-21 was obtained via
lentiviral transduction in human primary T-lymphocytes, resem-
bling the physiological upregulation of this miRNA that we observe
upon T-cell activation. This approach might reﬂect more closely the
mode of action of miRNAs in physiological conditions.
Despite the established role of miR-21 as a negative modulator
of apoptosis [31] we did not identify any effect on apoptosis of miR-
21 in T-lymphocytes.
miR-21 has been shown to promote AP-1 function in thyroid
cells through PDCD4 down-modulation [32]. However, we did not
observe any modulation of PDCD4, an explanation might be that T-
lymphocytes express a different isoform of PDCD4 which is not
targeted bymiR-21. In linewith the hypothesis thatmiRNA function
is determined by the speciﬁc cellular context, we highlight a novel
role of miR-21, which rather than enhancing MAP kinase signalling
and ERK phosphorylation in lymphocytes is a repressor of signal-
ling through this pathway. Our ﬁndings are consistent with the
observation that miR-21 limits adaptive immune response and af-
fects IFN-g production in murine lymphocytes [7].
Based on the observed phenotypes, we suggest that miR-21
expression could play a role in modulating TCR sensitivity of
memory T-cells, perhaps to avoid hyper-activation in response to
sub-optimal stimulation. Indeed, due to their extremely rapid and
strong response to TCR stimulation, sensitivity of TCR signalling
should be tightly controlled in memory T-cells, miR-21 may be a
candidate for this role. Further investigations will be required to
validate this hypothesis.
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